Harasha Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.46 Cr
as on 23-10-2024
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.30 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.56 Cr
as on 23-10-2024
- Revenue -1.88%
(FY 2023)
- Profit -45.87%
(FY 2023)
- Ebitda -96.49%
(FY 2023)
- Net Worth 25.07%
(FY 2023)
- Total Assets 10.15%
(FY 2023)
About Harasha Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.46 Cr.
The company currently has active open charges totaling ₹3.30 Cr. The company has closed loans amounting to ₹3.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manav Singla and Monika Singla serve as directors at the Company.
- CIN/LLPIN
U02423DL1997PTC084196
- Company No.
084196
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Harasha Pharma Private Limited offer?
Harasha Pharma Private Limited offers a wide range of products and services, including Pain Reliever Gel, Diclofenac Diethylamine Gel, Common Disease Medicines, Herbal Cough Syrup, Herbal Juice, Ayurvedic Medicine, Ayurvedic Kidney Medicine, Ayurvedic & Herbal Health Supplement, Wheat Flour, Aashirvaad Wheat Atta.
Who are the key members and board of directors at Harasha Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monika Singla  | Director | 10-May-2012 | Current |
| Manav Singla | Director | 02-Jan-1997 | Current |
Financial Performance of Harasha Pharma.
Harasha Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.88% decrease. The company also saw a substantial fall in profitability, with a 45.87% decrease in profit. The company's net worth Soared by an impressive increase of 25.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harasha Pharma?
In 2023, Harasha Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mannika Biotech Private LimitedActive 2 years 11 monthsManav Singla and Monika Singla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 30 Apr 2008 | ₹3.30 Cr | Open |
Canara Bank Creation Date: 09 Nov 2021 | ₹0.80 M | Satisfied |
Yes Bank Limited Creation Date: 19 Jun 2021 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Harasha Pharma?
Unlock and access historical data on people associated with Harasha Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harasha Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harasha Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
